Latest news
Why ResMed Is Dropping 6.1%: Piper Sandler Maintains Neutral - AlphaStreetAlphaStreet · Fri, 07 Aug 2026 22:32:31 GMTNET Maintained by Piper Sandler -- Price Target Raised to $333 - GuruFocusGuruFocus · Fri, 07 Aug 2026 22:07:49 GMTAKAM Maintained by Piper Sandler -- Price Target Lowered to $140 - GuruFocusGuruFocus · Fri, 07 Aug 2026 21:39:43 GMTU Maintained by Piper Sandler -- Price Target Raised to $55 - GuruFocusGuruFocus · Fri, 07 Aug 2026 20:36:36 GMTQSR Maintains Overweight by Piper Sandler -- Price Target Lowered to $81 - GuruFocusGuruFocus · Fri, 07 Aug 2026 20:26:15 GMTTAP Maintained by Piper Sandler -- Price Target Lowered to $44.0 - GuruFocusGuruFocus · Fri, 07 Aug 2026 19:52:30 GMTICUI Maintained by Piper Sandler -- Price Target Raised to $195 - GuruFocusGuruFocus · Fri, 07 Aug 2026 19:23:58 GMTRMD Maintained by Piper Sandler -- Price Target Lowered to $225 - GuruFocusGuruFocus · Fri, 07 Aug 2026 19:09:29 GMT